These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20607302)

  • 1. Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease.
    Büscher AK; Büscher R; Hauffa BP; Hoyer PF
    Pediatr Nephrol; 2010 Nov; 25(11):2295-301. PubMed ID: 20607302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease.
    Monzani A; Perrone M; Prodam F; Moia S; Genoni G; Testa S; Paglialonga F; Rapa A; Bona G; Montini G; Edefonti A
    Pediatr Nephrol; 2018 Apr; 33(4):661-672. PubMed ID: 29150712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones.
    Büscher AK; Cetiner M; Büscher R; Wingen AM; Hauffa BP; Hoyer PF
    Pediatr Nephrol; 2012 Nov; 27(11):2065-2071. PubMed ID: 22669322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-ghrelin and obestatin plasma levels in different stages of chronic kidney disease.
    Borges N; Moraes C; Barros AF; Carraro-Eduardo JC; Fouque D; Mafra D
    J Ren Nutr; 2014 Mar; 24(2):100-4. PubMed ID: 24462497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any interaction of resistin and adiponectin levels with protein-energy wasting among patients with chronic kidney disease.
    Kaynar K; Kural BV; Ulusoy S; Cansiz M; Akcan B; Misir N; Yaman S; Kaya N
    Hemodial Int; 2014 Jan; 18(1):153-62. PubMed ID: 23919731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.
    Canpolat N; Sever L; Agbas A; Tasdemir M; Oruc C; Ekmekci OB; Caliskan S
    Pediatr Nephrol; 2018 Nov; 33(11):2113-2122. PubMed ID: 29980850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute resistance exercise on acyl-ghrelin and obestatin levels in hemodialysis patients: a pilot study.
    Moraes C; Borges NA; Barboza J; Barros AF; Mafra D
    Ren Fail; 2015 Nov; 37(10):338-42. PubMed ID: 26381714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of resistance exercise training on acyl-ghrelin and obestatin levels in hemodialysis patients.
    Moraes C; Marinho S; Lobo JC; Stockler-Pinto MB; Barros AF; Jacobson LV; da Nobrega AC; Rosa ML; Denise M
    Ren Fail; 2015 Jun; 37(5):851-7. PubMed ID: 25897771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation.
    Arbeiter AK; Büscher R; Petersenn S; Hauffa BP; Mann K; Hoyer PF
    Nephrol Dial Transplant; 2009 Feb; 24(2):643-6. PubMed ID: 18809976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease.
    Naufel MF; Bordon M; de Aquino TM; Ribeiro EB; de Abreu Carvalhaes JT
    Pediatr Nephrol; 2010 Dec; 25(12):2477-82. PubMed ID: 20734087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin and leptin pathophysiology in chronic kidney disease.
    Gunta SS; Mak RH
    Pediatr Nephrol; 2013 Apr; 28(4):611-6. PubMed ID: 23229444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appetite-regulating hormones in chronic kidney disease patients.
    Oner-Iyidogan Y; Gurdol F; Kocak H; Oner P; Cetinalp-Demircan P; Caliskan Y; Kocak T; Turkmen A
    J Ren Nutr; 2011 Jul; 21(4):316-21. PubMed ID: 21193324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age modifies the association between serum obestatin, appetite and nutritional status in maintenance hemodialysis patients.
    Katkov A; Sinuani I; Azar A; Shapiro G; Efrati S; Beberashvili I
    Eur J Clin Nutr; 2018 Jul; 72(7):1007-1018. PubMed ID: 29362457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa.
    Nakahara T; Harada T; Yasuhara D; Shimada N; Amitani H; Sakoguchi T; Kamiji MM; Asakawa A; Inui A
    Biol Psychiatry; 2008 Aug; 64(3):252-5. PubMed ID: 17919459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin).
    Beasley JM; Ange BA; Anderson CA; Miller Iii ER; Holbrook JT; Appel LJ
    Obesity (Silver Spring); 2009 Feb; 17(2):349-54. PubMed ID: 19057526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are ghrelin and leptin involved in food intake and body mass index in maintenance hemodialysis?
    Mafra D; Jolivot A; Chauveau P; Drai J; Azar R; Michel C; Fouque D
    J Ren Nutr; 2010 May; 20(3):151-7. PubMed ID: 19913442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine role of stomach in appetite regulation in chronic kidney disease: about ghrelin and obestatin.
    Mafra D; Guebre-Egziabher F; Fouque D
    J Ren Nutr; 2010 Mar; 20(2):68-73. PubMed ID: 19913441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocytokines in Patients with Chronic Kidney Disease Stage 5.
    Yahya RS; Atwa MA; El-Sayed IH; El-Ghanaam DM; Hussein DT; El-Taweel FA
    Clin Lab; 2016; 62(1-2):21-30. PubMed ID: 27012030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Appetite-regulating Hormones and Body Composition in Pediatric Patients in Predialysis Stage of Chronic Kidney Disease and Healthy Control Group.
    Eftekhari MH; Ranjbar-Zahedani M; Basiratnia M; Rezaianzadeh A; Faghih S
    Iran J Med Sci; 2015 Jan; 40(1):27-33. PubMed ID: 25649956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes.
    Suneja M; Murry DJ; Stokes JB; Lim VS
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E55-64. PubMed ID: 20959536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.